SCHEMBL14529185

SCHEMBL14529185

Nc1nc(-c2ccccc2C(F)(F)F)nc2c(N)cccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 13/20 0.49
▸ CYP2D6 P10635 10/20 0.49
▸ CYP2C19 P33261 9/20 0.49
▸ CLK4 Q9HAZ1 5/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ RECQL P46063 1/20 0.49
▸ CYP3A4 P08684 9/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ USP1 O94782 7/20 0.45
▸ WDR48 Q8TAF3 7/20 0.45
▸ TSHR P16473 6/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13300121 0.84 CYP1A2 (0.63) CYP1A2CYP2D6CYP2C19CLK4CYP2C9
SCHEMBL14529277 0.76 PIP4K2C (0.59) CYP1A2CYP2D6CYP2C19CLK4CYP2C9
SCHEMBL15169425 0.76 MPL (0.45) MAPK1TSHRMEN1KMT2AKDM4E
SCHEMBL15169873 0.76 MPL (0.45) KDM4E
SCHEMBL15169486 0.76 MPL (0.45) CYP1A2KDM4E
SCHEMBL14529158 0.75 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C19CLK4CYP2C9
SCHEMBL14529396 0.75 CYP1A2 (0.51) CYP1A2CYP2D6CYP2C19CLK4CYP2C9
SCHEMBL14529155 0.74 CYP1A2 (0.49) CYP1A2CYP2D6CYP2C19CLK4CYP2C9
SCHEMBL15170212 0.73 ADORA2A (0.52) CYP1A2CYP2D6CYP2C19CYP2C9CYP3A4
SCHEMBL14471570 0.72 CYP1A2 (0.48) CYP1A2CYP2D6CYP2C19CLK4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318814-B1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMA (US) 2007-05-30 — — EP disclosed
Send feedback